185 related articles for article (PubMed ID: 25046026)
1. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
[TBL] [Abstract][Full Text] [Related]
2. Exploring an animal model of amodiaquine-induced liver injury in rats and mice.
Liu F; Cai P; Metushi I; Li J; Nakayawa T; Vega L; Uetrecht J
J Immunotoxicol; 2016 Sep; 13(5):694-712. PubMed ID: 27416278
[TBL] [Abstract][Full Text] [Related]
3. Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients.
Metushi IG; Hayes MA; Uetrecht J
Hepatology; 2015 Apr; 61(4):1332-42. PubMed ID: 25283142
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury.
Mak A; Uetrecht J
J Immunotoxicol; 2019 Dec; 16(1):28-33. PubMed ID: 30663942
[TBL] [Abstract][Full Text] [Related]
5. The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4.
Mak A; Uetrecht J
Chem Res Toxicol; 2015 Aug; 28(8):1567-73. PubMed ID: 26154582
[TBL] [Abstract][Full Text] [Related]
6. Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury.
Mak A; Uetrecht J
J Immunotoxicol; 2015; 12(4):361-7. PubMed ID: 25425471
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury.
Mak A; Johnston A; Uetrecht J
J Immunotoxicol; 2017 Dec; 14(1):89-94. PubMed ID: 28279082
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury.
Mak A; Cho TE; Uetrecht J
Chem Res Toxicol; 2018 Aug; 31(8):739-744. PubMed ID: 29938495
[TBL] [Abstract][Full Text] [Related]
9. Liver Injury Caused by Green Tea Extract in PD-1
Cho T; Wang X; Yeung K; Cao Y; Uetrecht J
Chem Res Toxicol; 2021 Mar; 34(3):849-856. PubMed ID: 33617238
[TBL] [Abstract][Full Text] [Related]
10. Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury.
Mak A; Cho T; Uetrecht J
J Immunotoxicol; 2018 Dec; 15(1):90-95. PubMed ID: 29733743
[TBL] [Abstract][Full Text] [Related]
11. The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury.
Mak A; Uetrecht J
Chem Res Toxicol; 2015 Dec; 28(12):2287-91. PubMed ID: 26529122
[TBL] [Abstract][Full Text] [Related]
12. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
Jee A; Sernoskie SC; Uetrecht J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
[TBL] [Abstract][Full Text] [Related]
13. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
Mak A; Kato R; Weston K; Hayes A; Uetrecht J
Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
[TBL] [Abstract][Full Text] [Related]
14. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid-induced liver injury and immune response in mice.
Metushi IG; Uetrecht J
J Immunotoxicol; 2014 Oct; 11(4):383-92. PubMed ID: 24303880
[TBL] [Abstract][Full Text] [Related]
16. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
Song B; Aoki S; Liu C; Susukida T; Ito K
Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
[TBL] [Abstract][Full Text] [Related]
17. The pro-fibrotic effects of pregnancy in a carbon-tetrachloride-induced liver injury in mouse model.
Amer J; Grifat R; Doron S; Abu-Tair L; Mruwat R; El-Khatib A; Safadi R
Liver Int; 2014 Sep; 34(8):1232-40. PubMed ID: 24325428
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of idiosyncratic drug-induced liver injury.
Uetrecht J
Adv Pharmacol; 2019; 85():133-163. PubMed ID: 31307585
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection.
Choi YH; Jin N; Kelly F; Sakthivel SK; Yu T
PLoS One; 2016; 11(10):e0165533. PubMed ID: 27788241
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer cells inhibits liver regeneration in toxin-induced liver injury model in mice via a tumor necrosis factor-alpha-dependent mechanism.
Wei H; Wei H; Wang H; Tian Z; Sun R
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G275-82. PubMed ID: 20448144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
